J Ga Public Health Assoc (2016), Supplement to Vol. 6, No. 2

ISSN 2471-9773

Literature Review
The Zika virus in the United States: A comprehensive review
Daniel R. Lindsey, MD Candidate, and Martin H. Greenberg, MD
Mercer University School of Medicine, Savannah, GA
Corresponding Author: Daniel R Lindsey 1250 East 66th St Savannah, GA 31404 (912)429-5735 dlindsey245@gmail.com

ABSTRACT
Background: With a series of outbreaks spanning the globe, the Zika virus has transitioned, in a short
time, from an obscure virus to a public health emergency. Locally transmitted Zika has reached the United
States, leading to increased concern regarding further transmission and the potential impact on public
health.
Methods: The present study was conducted to examine the propagation and effects of Zika in the United
States by reviewing published literature regarding Zika in conjunction with updates from the Centers for
Disease Control and Prevention. To gauge the regional response, including prevention and control efforts,
interviews were conducted with public health and mosquito control officials.
Results: Exposure to Zika may be through vectors, sexual activity with an infected partner, or congenitally
to the unborn fetus. Regardless of the mode of transmission, Zika infection may result in serious
neurological consequences in adults and especially in fetuses.
Conclusions: Prevention of Zika infection is key to successful control of the virus. Vector control and
surveillance as well as personal protection from virus exposure are necessary to avoid the potentially
devastating effects of the virus. In an effort to prevent further spread, public health authorities are
implementing strategies for public education, prevention, and containment.
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further spread of the virus. Across the United
States (US), hundreds of travel-related and
multiple sexually transmitted cases have been
reported (ECDPC, 2015; CDC: Case counts in
the US, 2016). In July 2016, cases identified in
Florida marked the first local transmission of
Zika in the continental US (CDC: Case Counts in
the US, 2016; CDC: FL investigation, 2016).
Relative to these outbreaks, this review examines
the propagation and potential effects of the Zika
virus in the US, including responses by front-line
public health authorities to prevent transmission
of the virus and to initiate protocols for
preparedness in the event of an outbreak.

INTRODUCTION
In a short time, the Zika virus has moved from a
relatively obscure virus to a cause of
international concern. Zika virus was first
isolated in 1947 in the Zika Forest of Uganda
during a yellow fever surveillance project (Dick,
1952). Since its discovery, Zika has remained
relatively benign, causing only sporadic, isolated
cases. In 2007, this changed as Zika re-emerged,
causing epidemic outbreaks in various islands of
the Pacific (Duffy et al., 2009; Ioos et al., 2014).
In the Americas, February 2015 marked the
beginning of a Zika pandemic that has sparked
international alarm. The outbreak began in Brazil
and quickly spread throughout South America
and the Caribbean. A high incidence of
neurological effects among Zika-infected adults
and fetuses led to a call for action to combat
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METHODS
This review was conducted by assessing
published literature regarding the Zika virus as
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well as current and updated guidance from the
Centers for Disease Control and Prevention
(CDC) via its website. In addition, unstructured
interviews were conducted with the administrator
and lead epidemiologist at the Georgia
Department of Public Health, Coastal District, to
investigate regional response protocols and
prevention efforts. Further, the director and the
lead entomologist of Chatham County Mosquito
Control were interviewed and were joined in the
field to examine vector control and surveillance
efforts currently underway.

concern regarding control of the virus. Sexually
transmitted cases have been reported across the
US (CDC: Case counts in the US, 2016). Zika
viral RNA has been detected in semen up to 93
days after the patient’s symptomatic period of
illness, indicating possible transmission to a
sexual partner months after infection (Musso,
Roche, Robin et al., 2015; Atkinson et al., 2016;
Brooks et al., 2016; Mansuy et al., 2016). A case
of probable sexual transmission from an infected
female to her male sexual partner has also been
reported (Davidson et al., 2016; Moreira et al.,
2016). In Brazil, there has been probable
transmission of Zika by transfusion of blood
products from an infected donor (Barjas-Castro
et al., 2016). The possibility of transmission of
Zika by transfusion has been suspected, as other
related viruses have been transmitted in this
manner (Lanteri et al., 2016; Musso, Stamer
et al., 2016).

RESULTS
Exposure
Although the Zika virus can be transmitted in
various ways, the primary route is via mosquito
vectors. During this vector transmission of Zika,
the virus in the saliva of an infected female
mosquito is transferred into the skin of a human
during a blood meal. The virus is deposited in
the epidermis and dermis of the host, infecting
several cell types that provide a haven for viral
replication and allow dissemination throughout
the body (Hamel et al., 2015). Although Zika
may be transmitted by several mosquito species,
in the Americas, Aedes aegypti, commonly
known as the yellow fever mosquito, appears to
serve as the main vector (Tilak et al., 2016). A.
aegypti is primarily an urban mosquito, meaning
that it prefers a habitat in close contact with
humans. The mosquito typically dwells around
or in homes, increasing the chances of viral
transmission. Females deposit their eggs in
small, stagnant bodies of water, preferring
household containers. Since adult A. aegypti
mosquitoes are relatively poor fliers, they tend to
dwell relatively close to their hatch site if a food
source is available, making them a persistent
nuisance once established around a home. In
recent years, the distribution of A. aegypti in the
US has declined, mainly due to the arrival of the
more competitive A. albopictus species.
Although some populations are still present in
the southern US, great numbers of A. aegypti are
primarily found only in Florida and regions
along the Gulf Coast (Zettel & Kaufman, 2013;
CDC: Dengue entomology and ecology, 2016;
Heusel & Moulis, communication). Despite the
wider distribution of A. albopictus, this species is
a less efficient vector of Zika and less likely to
cause a major outbreak (Chouin-Carneiro et al.,
2016; Hotez, 2016).

Although up to ninety percent of individuals
infected with Zika will be asymptomatic, those
developing symptoms generally suffer mild flulike symptoms of short duration that may be
accompanied by a maculopapular rash (Duffy
et al., 2009; Ioos et al., 2014; CDC: Zika virus
symptoms, 2016; Musso & Gubler, 2016). In
addition, Zika-infected individuals may be at a
greater risk for development of Guillain-Barré
syndrome (GBS). After the epidemics in the
Pacific and Brazil, an unusually high incidence
of new cases of GBS was reported for Zikainfected individuals (Arujo et al., 2016; Musso &
Gubler, 2016; Silva & Souza, 2016). GBS is an
acute-onset, autoimmune-mediated peripheral
polyneuropathy that can result subsequent to a
variety of infections or as a result of idiopathic
causes. The exact mechanism of GBS in the
context of Zika infection is unclear, but it has
been hypothesized that, during viral replication,
the virus may incorporate host gangliosides into
its makeup, eliciting an immune response that
cross-reacts with normal gangliosides of the host
causing self-reactivity against the peripheral
nervous system. The resulting demyelination
causes disruption in neural signaling and
potential axonal degradation (Anaya et al., 2016;
Cao-Lormeau et al., 2016). In severe cases,
muscle weakness and dysfunction, which are
commonly experienced, may compromise
breathing (Cao-Lormeau et al., 2016, Musso &
Gubler, 2016).
Vertical transmission of Zika from an infected
mother to her fetus during pregnancy has been
linked to congenital fetal Zika infections. Recent

In addition to vector transmission, Zika can be
transmitted by other means, leading to increased
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evidence, derived with animal models, has
suggested that the virus is transmitted to the fetus
across the placenta. Although the exact
mechanism by which the virus crosses the
placental membrane is uncertain, it has been
hypothesized that the virus crosses from the
maternal bloodstream in the chorionic villi to the
placenta, where it is amplified before spreading
into the fetal circulation and moving to infect
neural progenitor cells (NPCs) (Miner et al.,
2016; Quicke et al., 2016; Silva & Souza, 2016;
Wu et al., 2016).

Effective and efficient mosquito control is
dependent upon mosquito surveillance programs,
which allow for identification of the specific
mosquito species and their population numbers
in a particular area. This information can ensure
that mosquitoes, especially those that may serve
as disease vectors, can be targeted by control
efforts. Information collected from surveillance
may affect the type and amount of pesticide
applied, the method and time of application, and
area in which it is applied. In areas that lack a
professional mosquito agency, mosquito
surveillance is often nonexistent (Heusel &
Moulis, communication).

Congenital Zika infection of the developing fetus
may result in serious neurological defects,
including microcephaly, along with other
developmental anomalies primarily affecting the
central nervous system (Driggers et al., 2016;
Hazin et al., 2016; Kleber et al., 2016; Mlakar et
al., 2016; Musso & Gubler, 2016; Silva & Souza,
2016). In the US, as of July 2016, there have
been at least twelve newborns with congenital
birth defects due to Zika, with more cases likely
to follow (CDC: Outcomes of pregnancies,
2016). It is thought that the Zika virus is
associated more with a disruption in neural
development, rather than neural destruction
(Hazin et al., 2016). Cortical NPCs, which would
normally develop into the cerebral cortex, are a
key target for the virus. Infection of these cell
populations with Zika results in dysregulation of
the cell cycle and in attenuation of neural
development (Cugola et al., 2016; Li et al., 2016;
Tang et al., 2016). In Zika-infected fetuses,
ocular abnormalities, intrauterine growth
restriction, and fetal demise have also been
reported (Brasil et al., 2016; de Miranda et al.,
2016; de Paula Freitas et al., 2016; Mlakar et al.,
2016; Sarno et al., 2016).

In preparation for the Zika threat, some states
have taken a proactive approach to address the
lack of surveillance. The Georgia Department of
Public Health (GDPH), for example, has hired
new environmental health employees to conduct
surveillance in areas of the state where it is
lacking. This surveillance primarily follows A.
albopictus and A. aegypti, the two known vectors
of Zika in the US (Heusel & Moulis,
communication;
McCall
&
Thornton,
communication). Surveillance is conducted using
specially designed traps, such as the widely used
Biogents Sentinel® trap, that target both of these
Aedes species (Cornel et al., 2016; Heusel &
Moulis, communication). Once identified, the
species may be targeted by a combination of
adulticides and larvicides. Since both A.
albopictus and A. aegypti usually dwell in close
vicinity to homes and breed in household
containers, pesticide applications that target
these areas is essential for effective control (Rios
& Maruniak, 2011; Zettel & Kaufman, 2013;
CDC: Surveillance and control, 2016; Heusel &
Moulis, communication). In many areas, aerial
application may be beneficial, as this approach is
not limited by roadway access. This method,
however, may not be effective in treating
container-breeding sites in congested urban areas
(Heusel & Moulis, communication).

DISCUSSION
Prevention
With the potential of a major Zika outbreak in
the continental US, many state and local
agencies have stepped up efforts to prevent
spread of the virus. As the primary route of
transmission is via mosquito vectors, many of
these efforts are centered on mosquito control.
Effective control, however, is often challenging.
In most areas of the US, mosquito control is
dealt with on a local level with funding and
organization provided by local governments.
This can cause discontinuities across a region or
state, as many areas lack professional mosquito
control entities or may be poorly funded.

http://www.gapha.org/jgpha/

Controlling the vectors of Zika depends heavily
upon public involvement to help eliminate
mosquito-breeding sites around homes. In
response, public health officials urge the public
to become involved in the control effort. To
spread awareness, the GDPH has instituted a
public education campaign known as “Tip and
Toss.” The campaign urges citizens to be
involved in reducing mosquito-breeding sources
around their homes by emptying or eliminating
water-holding containers (GDPH: Tip ‘n toss,
2016; Rey & Connelly, 2016; McCall &

273

Georgia Public Health Association

J Ga Public Health Assoc (2016), Supplement to Vol. 6, No. 2

ISSN 2471-9773

Thornton, communication). Involvement of
entire communities is essential for the success of
such programs. Unfortunately, in some cases,
there may be residents who are reluctant or
refuse to participate. This allows mosquitobreeding sources to remain on properties and
may undermine the community effort (Petersen
et al., 2016; Heusel & Moulis, communication).
In addition to eliminating breeding sites,
authorities are striving to increase public
awareness concerning ways to prevent mosquito
bites through public outreach campaigns and
strategically placed informational signage, such
as in airports. To prevent mosquito bites,
officials advise wearing, while outdoors,
lightweight clothing that covers exposed areas of
skin and recommend, if outdoors for long
periods, treating clothing with permethrin to
deter mosquitoes (DeRaedt et al., 2015; CDC:
Zika virus prevent mosquito bites, 2016; GDPH:
Zika virus awareness campaign, 2016; McCall &
Thornton, communication). Perhaps the most
effective way to prevent mosquito bites is to
apply an effective insect repellant before going
outdoors. The most recommended personal
repellants are those containing DEET (20-30%),
although others containing picardin, Bayrepel,
icardin, and IR3535 are also approved by the
Environmental Protection Agency and CDC
(CDC: Zika virus prevent mosquito bites, 2016;
GDPH: Zika virus awareness campaign, 2016).
For those seeking a natural alternative to
synthetics, repellants containing oil of lemon
eucalyptus are effective (CDC: Zika virus
prevent mosquito bites, 2016).

women with a partner who has traveled to or
lives in a Zika area should utilize barriers
throughout the duration of pregnancy or abstain
from sexual activity to prevent potential
infection of the mother and fetus (Brooks et al.,
2016; CDC: Zika virus protect yourself during
sex, 2016).
The discovery, in Brazil, of probable Zika virus
transmission by blood transfusions has prompted
a federal effort to protect the US blood supply.
To prevent the distribution of infected blood
products, the Food and Drug Administration
(FDA) has issued guidelines for blood collection
centers, including immediate testing of all
donated blood products collected in the US
(FDA: FDA advises testing, 2016). Testing may
be conducted on individual blood donations by
use of a newly developed nucleic acid test.
Donated plasma and apheresis platelets may be
treated with pathogen reduction technology
(Kuehnert et al., 2016).
Containment
While prevention of Zika infection is the goal,
rapid identification and containment after an
infection occurs is essential to prevent an
isolated outbreak from developing into an
epidemic. With the arrival of Zika to the
continental US, federal, state, and local
authorities have prepared containment plans in
the event that an outbreak does occur. The first,
and perhaps the most important, step after an
infection is an accurate and timely diagnosis,
which is largely dependent on healthcare
providers. Upon examining a patient with
suspected Zika infection, providers are directed
to notify the Department of Public Health
immediately (CDC: Interim CDC Zika response
plan,
2016;
McCall
&
Thornton,
communication). Despite the fact that molecular
and serological testing has been made available
to state public health laboratories, accurate
diagnosis of Zika infection is difficult. Testing
may not yield a correct result depending on the
time of sampling and the high degree of cross
reactivity between related viruses. In many
cases, a series of tests requiring considerable
time, especially for laboratories with large test
loads, must be conducted to reach a definitive
result of infection status (CDC: Revised
diagnostic testing, 2016; Musso & Gubler, 2016;
Plourde & Bloch, 2016; McCall & Thornton,
communication).

In addition to preventing mosquito bites, care
should be taken to prevent sexual transmission of
Zika. All sexual couples in which one or both
partners live in areas of ongoing local
transmission or have traveled to these areas
should take precautions before engaging in any
form of sexual activity. This is especially
important for pregnant women and women who
are planning to become pregnant. Due to the
longevity of Zika particles in semen and their
unknown duration in vaginal fluids, the CDC
currently recommends that, for at least six
months after the symptomatic infection (or
suspected infection) of a partner, couples utilize
barriers before any type of intercourse. For
couples in which neither has experienced
symptoms, barriers are suggested for at least
eight weeks after travel to an area of local
transmission. Couples living in an area of
ongoing transmission should use barriers as long
as there is Zika reported in their area. Pregnant
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In the state of Georgia, once a suspected case is
reported, the GDPH contacts the patient as soon
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as possible, even if results of Zika testing are still
pending. The GDPH advises patients on methods
to prevent further local transmission, including
avoidance of unprotected sexual contact and
prevention of mosquito bites, which could spread
the virus to others. The GDPH (or local
mosquito control entities) may also conduct a
home visit and mosquito surveillance around the
index case site. If the area is conducive to
mosquito breeding, public authorities may
intervene to reduce the risk of transmission from
the index case (CDC: Interim CDC Zika
response plan, 2016; Ndeffo-Mbah et al., 2016;
Heusel & Moulis, communication; McCall &
Thornton, communication). The GDPH also
distributes educational materials throughout the
surrounding area, warning the residents of
possible Zika transmission and outlining steps to
protect themselves (GDPH: Zika virus awareness
campaign, 2016; McCall & Thornton,
communication). The CDC, also notified in the
case of potential local transmission, offers
support to local authorities. If needed, the CDC
activates emergency response teams to aid in
surveillance, vector control, communications,
and technical support at the scene (CDC: Interim
CDC Zika response plan, 2016).

several months to receive approval (Marshall &
Baylor, 2011; Pickering & Walton, 2013; Singh
& Mehta, 2016).
CONCLUSIONS
The Zika virus has recently emerged onto the
world stage, causing epidemic outbreaks
circumventing the globe. With the arrival of Zika
transmission to the US, public health authorities
and healthcare providers are preparing for new
outbreaks. Controlling mosquito vectors and
protecting people from exposure through
possible routes of transmission are key to
successful prevention. These efforts are of
paramount importance to prevent possible
infection of adults and developing fetuses. With
an effective vaccine possibly years away and no
specific treatment for Zika infection, prevention
and containment must be initiated immediately
to avoid the potentially devastating neurological
effects, including GBS in adults and
microcephaly in developing fetuses.
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Future outlook
No specific treatment or vaccine for Zika
infection currently exists, but researchers are
working
to
develop
these
life-saving
interventions. Investigators and public health
authorities are hopeful that a Zika vaccine is
attainable, as vaccines have been developed for
other flaviviruses (Dowd et al., 2016). Several
experimental vaccines have already entered
phase I clinical trials or are scheduled to begin
soon, including bacterial DNA-based vaccines
and a more traditional vaccine containing
inactivated virus (Inovio, 2016; NIH, 2016;
Pellerin, 2016). A recent study with murine
models has found both DNA-based and
inactivated viral vaccines to be effective and
shows promise for use in humans (Larocca et al.,
2016).
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